CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-05-17 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2017-05-17 | Troendle August J. Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2017-05-17 | Richards Christos Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2017-05-17 | Wahlstrom Mats Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2017-05-09 | Wahlstrom Mats Director | Other disposition | −200,000 | 178,528 | ||
| 2017-05-09 | Wahlstrom Mats Director | Other acquisition | +109,957 | 219,914 | ||
| 2017-05-01 | Herman Alan C. Chief Scientific Officer | Sale | −11,333 | $20.00 | $227K | 79,119 |
| 2017-04-03 | Herman Alan C. Chief Scientific Officer | Sale | −11,333 | $20.73 | $235K | 90,452 |
| 2017-03-01 | Herman Alan C. Chief Scientific Officer | Sale | −11,333 | $24.19 | $274K | 101,785 |
| 2017-02-22 | Wahlstrom Mats Director | Other disposition | −200,000 | 378,528 | ||
| 2017-02-22 | Wahlstrom Mats Director | Other acquisition | +109,957 | 109,957 | ||
| 2017-02-01 | Herman Alan C. Chief Scientific Officer | Sale | −11,333 | $27.37 | $310K | 113,118 |
| 2017-01-25 | Viret Jean-Frederic Chief Financial Officer | Option exercise | +3,900 | $13.50 | $53K | 6,892 |
| 2017-01-25 | Viret Jean-Frederic Chief Financial Officer | Sale | −3,900 | $27.00 | $105K | 2,992 |
| 2017-01-25 | Viret Jean-Frederic Chief Financial Officer | Option exercise · Stock Option (right to buy) | −3,900 | 112,481 | ||
| 2017-01-03 | Herman Alan C. Chief Scientific Officer | Sale | −10,650 | $27.90 | $297K | 125,134 |
| 2017-01-03 | Herman Alan C. Chief Scientific Officer | Sale | −683 | $28.60 | $20K | 124,451 |
| 2016-12-19 | Viret Jean-Frederic Chief Financial Officer | Option exercise | +667 | $13.50 | $9K | 2,992 |
| 2016-12-19 | Viret Jean-Frederic Chief Financial Officer | Option exercise · Stock Option (right to buy) | −667 | 116,381 | ||
| 2016-12-16 | Viret Jean-Frederic Chief Financial Officer | Option exercise | +3,900 | $13.50 | $53K | 6,225 |
Page 25 of 39 · 768 trades